Robert J Soiffer

During the past 25 years, hematopoietic stem cell transplantation (HSCT) has become accepted as routine treatment for many patients with hematologic malignancies. Traditionally, the primary biologic objectives of HSCT for malignant disease and marrow disorders include the following:

• Delivery of chemotherapy/radiotherapy sufficient to destroy tumor cells

• Infusion of a source of hematopoietic stem cells to replace damaged lymphoid or myeloid progenitors

• Establishment of organ graft tolerance to prevent rejection of donor cells

• Induction of graft-versus-tumor (GVT) activity by allo-geneic immune effector cells

Recent laboratory and clinical observations on the biology of transplantation have challenged many of the fundamental beliefs and practices established over the past quarter century. Insights into graft-versus-host disease (GVHD), graft-versus-leukemia (GVL) activity, stem cell engraftment, donor selection, minimal residual disease (MRD), infectious complications, and treatment-related organ dysfunction all have contributed to revisions and refinements in the current approach to potential transplant recipients.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment